Home Cart 0 Sign in  
X

[ CAS No. 6967-12-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 6967-12-0
Chemical Structure| 6967-12-0
Chemical Structure| 6967-12-0
Structure of 6967-12-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 6967-12-0 ]

Related Doc. of [ 6967-12-0 ]

Alternatived Products of [ 6967-12-0 ]

Product Details of [ 6967-12-0 ]

CAS No. :6967-12-0 MDL No. :MFCD00005696
Formula : C7H7N3 Boiling Point : -
Linear Structure Formula :- InChI Key :KEJFADGISRFLFO-UHFFFAOYSA-N
M.W : 133.15 Pubchem ID :81423
Synonyms :

Calculated chemistry of [ 6967-12-0 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 2.0
Molar Refractivity : 40.5
TPSA : 54.7 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.01 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.49
Log Po/w (XLOGP3) : 1.55
Log Po/w (WLOGP) : 1.15
Log Po/w (MLOGP) : 0.51
Log Po/w (SILICOS-IT) : 1.36
Consensus Log Po/w : 1.01

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.31
Solubility : 0.655 mg/ml ; 0.00492 mol/l
Class : Soluble
Log S (Ali) : -2.31
Solubility : 0.655 mg/ml ; 0.00492 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.52
Solubility : 0.404 mg/ml ; 0.00303 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.35

Safety of [ 6967-12-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 6967-12-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 6967-12-0 ]
  • Downstream synthetic route of [ 6967-12-0 ]

[ 6967-12-0 ] Synthesis Path-Upstream   1~11

  • 1
  • [ 6967-12-0 ]
  • [ 23244-88-4 ]
YieldReaction ConditionsOperation in experiment
87% at 0 - 120℃; General procedure: To a suspension of corresponding amine (1 equiv) in H2O/98percent H2SO4 (1:1) was added NaNO2 (1 equiv) slowly at 0 °C. After stirred at 120 °C for 2 h, the mixture was diluted with water (30 mL) and extracted with ethyl acetate (30 mL x 3). The combined organic layer was dried over Na2SO4 and concentrated. The residue was purified by silica gel column chromatography (dichloromethane/methanol) to afford the desired products 26 and 27. 6.1.12.1
H-Indazol-6-ol (26)
Orange solid (yield: 87percent).
1H NMR (400 MHz, DMSO-d6): δ 12.55 (s, 1H), 9.56 (s, 1H), 7.85 (s, 1H), 7.51 (d, J = 8.8 Hz, 1H), 6.75 (s, 1H), 6.62 (dd, J = 8.8, 1.6 Hz, 1H).
87%
Stage #1: With sulfuric acid; sodium nitrite In water at 20℃; for 2 h; Cooling with ice
Stage #2: at 120℃; for 2 h;
AB27-1 (80 mg, 0.60 mmol) was dissolved in water / concentrated sulfuric acid (0.6 mL: 0.6 mL) The sodium nitrite (42 mg, 0.60 mmol) was slowly added under ice bath and allowed to react at room temperature for 2 hours. Subsequently, water (10 mL) was added and the temperature was raised to 120 ° C for 2 hours. Add saturated aqueous solution of sodium bicarbonate to adjust pH to 7. Water (30 mL) was added and extracted with ethyl acetate (30 mL * 3). The combined organic phases were washed with saturated brine (30 mL * 2), dried over anhydrous sodium sulfate, concentrated under reduced pressure and purified by column chromatography (dichloromethane : Methanol = 20: 1) to give a yellow solid (707mg, 87percent)
55.6% With sulfuric acid In water at 0 - 110℃; for 2 h; To a suspension of compound 92-1 (4.5 g, 33.8 mmol) in 20 mL of ice water was added 6 mL of cone, sulfuric acid dropwise at 0 °C. The mixture was stirred at room temperature for 1 h and then heated to 110 °C for another hour. The mixture was cooled and adjusted to pH 6 with 2 M sodium hydride to give a suspension. The suspension was filtered. The solid was collected and dried in vacuo to afford the crude product as a brown solid (2.5 g, yield: 55.6percent). MS (ESI): m/z 135 [M+H]+.
51%
Stage #1: at 170℃; for 1 h; Microwave irradiation
Stage #2: With sodium hydroxide In water for 0.166667 h;
Example 38 IV-5 Preparation of 6-[4-(4-(3-(6-fluoro-benzisoxazolyl))-1-piperazinyl)-n-butoxy]-(1H)-indazole 6-aminoindazole (2.66g, 20 mmol) is added to 20percent of dilute sulfuric acid and the reaction is performed under microwave radiation at 170°C for 1 hour using microwave powder of 600 watt, and then terminated. The reaction solution is cooled, adjusted to pH=7 with 5percent NaOH and stirred for 10 minutes to precipitated a deposit, which is recrystallized in water to obtain 1.5g of 6-hydroxyindazole, with a yield of 51 percent. 6-hydroxyindazole and 3-(1-(4-chlorobutyl)-4-piperidinyl)-6-fluoro-benzisoxazole are used as starting materials and react according to step 4 in the method of preparation of IV-1 to obtain 6-[4-(4-(3-(6-fluoro-benzisoxazolyl))-1-piperazinyl)-n-butoxy]-(1H)-indazole, with a yield of 62percent. Element analysis: C23H23FN4O2(calculated valuepercent: C 66.99,H 5.88, N 14.20; found valuepercent: C 66.71, H 5.80, N 13.89) 1HNMR(DMSO-d6): 8.21-6.49,(6H,aromatic ring-H), 4.18-4.19(2H, piperazine-H), 3.87(m,5H, O-CH2,) 3.66-3.75(2H, piperazine-H), 3.25-3.54(m, 6H), 2.79(t, J=8Hz, 2H),2.42(t, J=8Hz, 2H)1.71-1.90(m, 4H) MS : m/z 394
51% at 170℃; for 1 h; Microwave irradiation 6-aminoindazole (2.66 g, 20 mmol) was added to 20percent diluted sulfuric acid and reacted in a microwave reactor at 170 ° C. for 1 hour, microwave output was 600 W. The reaction is stopped, cooled, adjusted to pH 7 with 5percent NaOH, stirred for 10 minutes, precipitate is precipitated and recrystallized from water to give 1.5 g of 6-hydroxyindazole. Yield is 51percent.

Reference: [1] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 21, p. 6855 - 6868
[2] Patent: CN104876912, 2017, B, . Location in patent: Paragraph 0047; 0201-0204
[3] Journal of Medicinal Chemistry, 2010, vol. 53, # 5, p. 2324 - 2328
[4] Patent: WO2004/39796, 2004, A1, . Location in patent: Page/Page column 60-61
[5] Patent: WO2013/169964, 2013, A1, . Location in patent: Paragraph 00369; 00370
[6] Patent: EP2322520, 2011, A1, . Location in patent: Page/Page column 25-26
[7] Patent: JP5714152, 2015, B2, . Location in patent: Page/Page column 31
[8] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 4, p. 1966 - 1982
[9] Chemische Berichte, 1890, vol. 23, p. 3642[10] Chemische Berichte, 1892, vol. 25, p. 3152
[11] Justus Liebigs Annalen der Chemie, 1914, vol. 404, p. 84
[12] Journal of the American Chemical Society, 1926, vol. 48, p. 1101
[13] Journal of the Chemical Society, 1955, p. 2412,2419
[14] Bulletin de la Societe Chimique de France, 1950, p. 466,476
[15] Patent: EP2103620, 2009, A1, . Location in patent: Page/Page column 75-76
[16] Patent: US2010/152265, 2010, A1, . Location in patent: Page/Page column 51
[17] Patent: US2010/160256, 2010, A1, . Location in patent: Page/Page column 51
[18] Patent: WO2007/95124, 2007, A2, . Location in patent: Page/Page column 108-109
[19] Patent: EP2484668, 2012, A1,
[20] Journal of Medicinal Chemistry, 2015, vol. 58, # 15, p. 6048 - 6057
  • 2
  • [ 7597-18-4 ]
  • [ 6967-12-0 ]
YieldReaction ConditionsOperation in experiment
94% With hydrogen In methanol A mixture of 6-nitro-1H-indazole (25 g, 0.153 mmol, commercially available) and 10percent Pd/C (2.0 g) in MeOH was stirred under H2 (1 atm) overnight. After filtration, the filtrate was concentrated to yield 1H-indazol-6-ylamine (18.5 g, 94percent yield) as a yellow solid.
92% With palladium 10% on activated carbon; hydrogen In methanol at 20℃; General procedure: To a solution of corresponding nitrobenzene (1 equiv) in methanol (20 mL) was added Pd/C (10percent), and the mixture was stirred at room temperature under H2 overnight. The mixture was filtered,and the filtrate was concentrated to afford the desired products 24 and 25. 6.1.11.1
1H-Indazol-6-amine (24)
Yellow solid (yield: 92percent).
1H NMR (400 MHz, DMSO-d6): δ 12.25 (s, 1H), 7.71 (s, 1H), 7.35 (d, J = 8.4 Hz, 1H), 6.52-6.43 (m, 2H), 5.21 (s, 2H).
92% With palladium on activated charcoal; hydrogen In methanol at 20℃; for 12 h; Β24-1(1.5 g, 9.2 mmol) was dissolved in methanol (20 mL), Pd / C (150 mg) was added under nitrogen, replaced twice with hydrogen, Under normal pressure and pressure under hydrogen protection for 12 hours, diatomaceous earth filter, the filtrate was concentrated under reduced pressure yellow solid (l.lg, 92percent).
90% With hydrazine In ethanol at 60℃; for 8 h; Inert atmosphere; Sealed tube General procedure: To a sealed tube containing the nitro compound (0.6 mmol) and 2 mL ethanol were added 2.6–6.0 mmol of NH2NH2 (see Table 2) and Au/TiO2 (100 mg, 1 wt.percent in [Au], 0.8 molpercent). The reaction was heated at 60 °C for an appropriate time (see Table 2) under an inert atmosphere. The reaction was monitored by TLC, and after completion, the slurry was filtered under pressure through a short pad of celite and silica gel to withhold the supported catalyst with the aid of ethanol or methanol (~ 5 mL). The filtrate was evaporated under vacuum to afford the corresponding amines in pure form. The spectroscopic data (1H NMR, 13C NMR) of amines 1a–20a are in agreement with those previously reported [28,30,31], while the majority of them are commercially available substances. The screened catalysts Au/TiO2, Au/Al2O3, and Au/ZnO (~ 1 wt.percent in Au) are commercially available (Strem Chemicals), and have an average gold crystallite size of ~ 2–3 nm.

Reference: [1] Tetrahedron Letters, 2010, vol. 51, # 5, p. 786 - 789
[2] ChemCatChem, 2014, vol. 6, # 11, p. 3153 - 3159
[3] Tetrahedron, 2008, vol. 64, # 28, p. 6711 - 6723
[4] Patent: WO2006/71940, 2006, A2, . Location in patent: Page/Page column 407
[5] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 11, p. 3177 - 3180
[6] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 21, p. 6855 - 6868
[7] Patent: CN104876912, 2017, B, . Location in patent: Paragraph 0047; 0184-0187
[8] Catalysis Communications, 2013, vol. 36, p. 48 - 51
[9] RSC Advances, 2014, vol. 4, # 43, p. 22567 - 22574
[10] ACS Catalysis, 2014, vol. 4, # 10, p. 3504 - 3511
[11] Synlett, 2006, # 7, p. 1043 - 1046
[12] Chemische Berichte, 1890, vol. 23, p. 3642[13] Chemische Berichte, 1892, vol. 25, p. 3152
[14] Chemische Berichte, 1896, vol. 29, p. 308
[15] Justus Liebigs Annalen der Chemie, 1927, vol. 451, p. 285,302
[16] Journal of the American Chemical Society, 1943, vol. 65, p. 1804,1805
[17] Justus Liebigs Annalen der Chemie, 1927, vol. 454, p. 306
[18] Journal of the American Chemical Society, 1926, vol. 48, p. 1101
[19] European Journal of Medicinal Chemistry, 2012, vol. 57, p. 240 - 249
[20] Patent: WO2016/57834, 2016, A1, . Location in patent: Paragraph 000327
[21] Tetrahedron, 2017, vol. 73, # 48, p. 6805 - 6814
  • 3
  • [ 99-55-8 ]
  • [ 6967-12-0 ]
Reference: [1] Chemische Berichte, 1890, vol. 23, p. 3642[2] Chemische Berichte, 1892, vol. 25, p. 3152
[3] Chemische Berichte, 1890, vol. 23, p. 3642[4] Chemische Berichte, 1892, vol. 25, p. 3152
  • 4
  • [ 64-17-5 ]
  • [ 7783-06-4 ]
  • [ 7597-18-4 ]
  • [ 6967-12-0 ]
Reference: [1] Chemische Berichte, 1890, vol. 23, p. 3642[2] Chemische Berichte, 1892, vol. 25, p. 3152
  • 5
  • [ 6967-12-0 ]
  • [ 348-25-4 ]
Reference: [1] Journal of Medicinal Chemistry, 2015, vol. 58, # 15, p. 6048 - 6057
  • 6
  • [ 6967-12-0 ]
  • [ 73907-98-9 ]
Reference: [1] Journal of Organic Chemistry, 1980, vol. 45, # 15, p. 3072 - 3077
[2] Tetrahedron Letters, 1980, vol. 21, # 32, p. 3029 - 3032
  • 7
  • [ 6967-12-0 ]
  • [ 73907-95-6 ]
Reference: [1] Journal of Organic Chemistry, 1980, vol. 45, # 15, p. 3072 - 3077
[2] Tetrahedron Letters, 1980, vol. 21, # 32, p. 3029 - 3032
  • 8
  • [ 6967-12-0 ]
  • [ 79762-54-2 ]
YieldReaction ConditionsOperation in experiment
48%
Stage #1: With hydrogen bromide; sodium nitrite In water at 0℃; for 0.25 h;
Stage #2: With copper(I) bromide In water at 20 - 80℃; for 1.5 h;
6-Aminoindazole (1.33 g, 10 mmol) was dissolved in 48percent hydrobromic acid (5 mL) and water (16 mL). To the resulting solution at 0° C. was added dropwise a solution of sodium nitrite (0.77 g, 11 mmol) in water (9 mL). The mixture was stirred at 0° C. for 15 min. Urea (0.40 g) was added to remove excess nitrous acid. After stirring for 10 min, this solution was added dropwise to a stirred mixture of copper(I) bromide (4.3 g, 30 mmol), 48percent hydrobromic acid (10 mL) and water (24 mL) at room temperature. The reaction mixture was heated at 75-80° C. for 1.5 h, cooled to room temperature, basified with concentrated ammonium hydroxide, and extracted with chloroform (4.x.30 mL). The combined extracts were dried over sodium sulfate and concentrated to provide the bromoindazole (0.96 g, 48percent) as a greenish yellow solid; 1H NMR (500 MHz, DMSO-d6) δ 13.16 (s, 1H), 8.09 (s, 1H), 7.67 (s, 1H), 7.74-7.72 (d, J=8.5 Hz, 1H), 7.25-7.23 (dd, J=8.5, 1.4 Hz, 1H).
Reference: [1] Patent: US2006/142307, 2006, A1, . Location in patent: Page/Page column 8
  • 9
  • [ 6967-12-0 ]
  • [ 12775-96-1 ]
  • [ 79762-54-2 ]
YieldReaction ConditionsOperation in experiment
16% With hydrogen bromide; sodium nitrite In hexane; water; ethyl acetate (i)
6-Bromo-1H-indazole
Sodium nitrite (315 mg, 4.56 mmol) was added in 2 portions to an ice-cooled suspension of 6-aminoindazole (500 mg, 3.8 mmol) in water (0.4 mL) and hydrobromic acid (48percent, 1.8 mL).
The reaction mixture was stirred for 10 minutes longer than required for the brown gas to disappear.
Copper powder (35 mg, 0.55 mmol) was then added and the mixture heated gently until nitrogen evolution began.
The reaction mixture was then alternately heated and cooled to control the rate of reaction.
When nitrogen evolution ceased, the reaction mixture was heated at 90° C. for 30 minutes, cooled to room temperature, neutralized with aqueous sodium hydroxide and the product extracted into ethyl acetate.
The organic layer was washed sequentially with water and brine, dried over sodium sulfate and the solvent removed in vacuo.
Flash chromatography on silica gel (20-40percent ethyl acetate in hexane) yield the title product (119 mg, 16percent).
Reference: [1] Patent: US6380242, 2002, B1,
  • 10
  • [ 6967-12-0 ]
  • [ 261953-36-0 ]
YieldReaction ConditionsOperation in experiment
80%
Stage #1: With hydrogenchloride; sodium nitrite In water at 0℃; for 0.5 h;
Stage #2: With potassium iodide In dichloromethane; water at 0 - 40℃; for 2.16667 h;
A concentrated hydrochloric acid (35 mL, 420 mmol) and an aqueous solution (30 mL) of sodium nitrite (6.64g, 96 mmol) were added to a suspension prepared by adding water (30 mL) to 6-aminoindazole (10.4 g, 78 mmol) at0°C and stirred at 0°C for 30 minutes. Subsequently, to this solution, an aqueous solution (30 mL) of potassium iodide(15.91 g, 96 mmol) was added at 0°C, stirred at room temperature for 30 minutes, to which dichloromethane (80 mL)was then added, and stirred at 40°C for 2 hours. The reaction mixture was cooled down to 0°C, then adjusted to pH =14 with a 3N sodium hydroxide aqueous solution, and the precipitate was taken by filtration. The resulting precipitatewas washed with 10percent sodium thiosulfate, dissolved in tetrahydrofuran, and then silica gel was added. After stirring atroom temperature for 1 hour, hexane (600 mL) was added and filtered. The residue was washed twice with a THF/hexane(1/3 (v/v)) solution, then the solvent was distilled away under a reduced pressure to obtain the title compound (15.23 g,80percent) as an orange powder.1H NMR (400 MHz, CDCl3) δ 10.24 (1H, br, s), 8.04 (1H, br s), 7.92 (1H, br s), 7.51 (1H, br d, J = 8.4 Hz), 7.46 (1H, dd,J = 8.4, 1.2 Hz).
48% With sodium hydroxide; concentrated aqueous HCl; Ki; sodium hydrogencarbonate; sodium nitrite In tetrahydrofuran; hexane; water (i)
To 6-aminoindazole (40.8 g, 0.3065 mol, 1 equiv) in a 2-liter (2-L) round-bottom flask containing a large magnetic stir bar was added ice (256 g), followed by water (128 mL) and the reaction vessel was lowered into an ice bath.
To this stirring slurry at 0° C. was added concentrated aqueous HCl (128 mL, 1.53 mol, 5 equiv).
Immediately after, a solution of NaNO2 (23.3 g, 0.338 mol, 1.1 equiv) in water (96 mL) was added.
After 10 min of stirring at 0° C., KI (61 g, 0.368 mol, 1.2 equiv) was added very slowly at first (~100 mg at a time because the first small bits of KI cause an abrupt evolution of gas) then more rapidly (5 min total time).
The cold bath was removed and the reaction mixture was warmed to 40° C. (gas evolved).
When the rate of gas evolution decreased (~30 min) the reaction mixture was warmed to 50° C. for 30 min.
The mix was then cooled to 23° C., and 3N NaOH (320 mL) was added to neutralize followed by 50percent saturated NaHCO3 (320 mL).
The slurry was then filtered through a Buchner funnel to give a dark reddish-brown solid.
The solid was taken up in warm THF (800 mL) and silica (600 mL dry) was added with stirring.
To this slurry was added hexane (1.2 L) and the mix was vacuum filtered through a pad of silica (300 mL) in a large fritted filter.
The silica was further washed with 2 L of 40percent THF in hexane.
The filtrates were combined and concentrated under reduced pressure to give a solid.
The solid was further triturated with ethyl acetate (~100 mL), filtered and dried under reduced pressure to give 6-iodo-1H-indazole as a light brown solid (36.1 g, 48percent yield): Rf sm 0.12, p 0.48 (Hex-EtOAc 1:1); 1H NMR (300 MHz, CDCl3) 7.9 (s, 1H), 7.8 (s, 1H), 7.42 (d, 1H), 7.33 (d, 1H); MS (ES) [m+H]/z Calc'd 245, Found 245, [m-H]/z Calc'd 243, Found 243.
0.9 g
Stage #1: With hydrogenchloride; sodium nitrite In water at 0℃; for 0.166667 h;
Stage #2: With potassium iodide In water at 40 - 50℃; for 1.16667 h;
6-Aminoindazole (1.0 g, 7.5 mmol) was mixed with ice (6 g) and water (3.5 mL). The reaction mixture was cooled to 0°C and concentrated aqueous hydrochloride solution (3.8 mL) was added followed by a solution of sodium nitrite (0.6 g, 8.2 mmol) in water (2.5 mL). After 10 min of stirring at 0°C potassium iodide (1.3 g, 9.0 mmol) was added in few portions. Then the cold bath was removed and reaction mixture was warmed to 40°C, heated for 40 min and next the temperature was increased to 50°C and heated for another 30 min. After cooled to ambient temperature the solution was alkalized with 10percent NaOH. The brown precipitate was collected by filtration and washed with saturated aqueous solution of sodium hydrogen carbonate. The crude product was dissolved in tetrahydrofuran (25 mL) and refluxed with silica gel for 10 min. To this slurry hexane was added and the mixture was vaccum filtered through a silica pad. The silica was washed with solution of tetrahydrofuran in hexane (2:3). The filtrate was concentrated under reduced pressure to give 6-iodoindazole (0.9 g). The 6-iodoindazole (0.9 g, 3.9 mmol) was dissolved in dry dichloromethane (30 mL), cooled to 0°C and N- bromosuccinimide (0.8 g, 4.3 mmol) was added in portions. The reaction mixture was stirred at 0°C for lh. The precipitate was collected by filtration and washed with dichloromethane. The obtained product 3-bromo-6-iodo-lH-indazole was used to the next step without further purification. LC-MS (m/z) 324.8 (M+l).
Reference: [1] Patent: EP3127900, 2017, A1, . Location in patent: Paragraph 0250; 0251
[2] Patent: US6531491, 2003, B1,
[3] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 11, p. 3177 - 3180
[4] Patent: US6716837, 2004, B1, . Location in patent: Page column 30
[5] Patent: WO2017/68064, 2017, A1, . Location in patent: Page/Page column 183; 184
  • 11
  • [ 6967-12-0 ]
  • [ 821-48-7 ]
  • [ 763910-07-2 ]
Reference: [1] Journal of Medicinal Chemistry, 2010, vol. 53, # 21, p. 7639 - 7646
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 6967-12-0 ]

Amines

Chemical Structure| 19335-11-6

[ 19335-11-6 ]

5-Aminoindazole

Similarity: 0.96

Chemical Structure| 101257-89-0

[ 101257-89-0 ]

4-Methyl-1H-indazol-5-amine

Similarity: 0.94

Chemical Structure| 81115-60-8

[ 81115-60-8 ]

5-Methyl-1H-indazol-4-amine

Similarity: 0.92

Chemical Structure| 41748-71-4

[ 41748-71-4 ]

4-Amino-1H-indazole

Similarity: 0.92

Chemical Structure| 267413-25-2

[ 267413-25-2 ]

(1H-Indazol-5-yl)methanamine

Similarity: 0.92

Related Parent Nucleus of
[ 6967-12-0 ]

Indazoles

Chemical Structure| 271-44-3

[ 271-44-3 ]

1H-Indazole

Similarity: 0.98

Chemical Structure| 19335-11-6

[ 19335-11-6 ]

5-Aminoindazole

Similarity: 0.96

Chemical Structure| 101257-89-0

[ 101257-89-0 ]

4-Methyl-1H-indazol-5-amine

Similarity: 0.94

Chemical Structure| 3176-63-4

[ 3176-63-4 ]

4-Methyl-1H-indazole

Similarity: 0.94

Chemical Structure| 41748-71-4

[ 41748-71-4 ]

4-Amino-1H-indazole

Similarity: 0.92